News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

June 1997

Cost of Illness Studies for Schizophrenia: Components, Benefits, Results, and Implications

ByLaura A. Genduso, PharmD,Jane Castelli Haley, MBA

June 1st 1997

Issues of Medical Necessity: A Medical Director's Guide to Good Faith Adjudication

ByCampion Quinn, MD

June 1st 1997

Asthma Treatment Costs Using Inhaled Corticosteroids

BySusan Sedory Holzer, MA,Luella Engelhart, MS,William H. Crown, PhD,Todd A. L'Herrou, MA,Sean T. Kennedy

June 1st 1997

Costs, True Costs, and Whose Costs in Economic Analyses in Medicine?

ByGeorge A. Macones, MD, MSCE,David A. Asch, MD, MBA

June 1st 1997

The Challenge of Integrating Monoclonal Antibodies into the Current Healthcare System

ByScott A. Bull, PharmD,Diana I. Brixner, PhD, RPh

June 1st 1997

Prostate Cancer Screening

ByJohn A. Fracchia, MD,Hugh Straley, MD,John Wennberg, MD, MPH,Robin L. Smith, MD

June 1st 1997

Breast Reconstruction After Mastectomy

ByPaul R. Weiss, MD

June 1st 1997

Exploring Self-Care and Wellness: A Model for Pharmacist Compensation by Managed Care Organizations

ByQuentin Srnka, PharmD, MBA,Tracy S. Portner, PhD

June 1st 1997

Breast-Feeding and Managed Care

ByGary R. Brickner, MD

June 1st 1997

Correspondence regarding, "The Political Economy of Capitated Managed Care"

ByMary E. Stuart, ScD,Michael Weinrich, MD,Author reply by Douglas W. Emery, MS and Roberta Q. Herzberg, PhD

June 1st 1997

Economic Advantages of Breast-Feeding in an HMO Setting: A Pilot Study

ByChristine Hoey, RN,Julie L. Ware, MD

June 1st 1997

Trending on AJMC

New Legislation Aims to Address Transparency in PBMs as First Major Step in Reform

FDA to Restrict Ingredients Used in Mass-Marketed Compounded GLP-1s, Crack Down on Misleading Ads

Catchment Areas Shape Diversity and Access in Oncology Trials: Amir Fathi, MD

Medicare’s 3-Day Rule Reinstatement Lengthened Hospital Stays Without Cost, Outcome Benefits

Advances in MASLD and MASH Care Highlight Progress and Persistent Gaps